The MIND Foundation is a a psychedelic research and education organization committed to a healthier, more connected world through evidence-based, safe, and legal applications of the psychedelic experience.
The Augmented Psychotherapy Training (APT) is a two-year program that provides you with the knowledge and skills you need to practice psychedelic-augmented psychotherapy and psychedelic integration therapy in a legal, safe, and evidence-based framework.
Country
Germany
Contact Person / Email
https://mind-foundation.org/apt
Beyond Experience is a course that provides a comprehensive skill set for working with the whole spectrum of psychedelic experiences, both personally and when supporting others. The course’s main goal is to engage in a deep integration process and help you remember and express your psychedelic experiences.
Contact Person / Email
integration@mind-foundation.org
Footsteps is an online integrated journey in which you learn to integrate psychedelic experiences online. Over the course of six weeks, you will reconnect deeply with one of your psychedelic experiences in order to identify and embody the insights you have gained in sustainable ways.
The MIND Integration Facilitator Training is training for those who have participated in BEYOND EXPERIENCE (BE) and FOOTSTEPS and want to bring the integrative approach to the psychedelic experience into the world.
The MIND Philosophy series intends to provide an accessible overview of philosophical issues that arise in relation to psychedelics, psychedelic use, and psychedelic research.
The Molecules Program offers a unique transdisciplinary and evidence-based approach to knowledge about psychoactive substances. Being the first program of its kind, we have developed this platform for academics, health practitioners, and the general public. You will be able to acquire and integrate knowledge and practices from different disciplines and professions.
The EPIsoDE Study is being conducted by the Central Institute of Mental Health (CIMH) in Mannheim, Germany (Principal Investigator: Prof. Dr. med. Gerhard Gründer). A second study center has been established at Charité Universitätsmedizin Berlin. The study is funded by the German Federal Ministry of Education and Research (BMBF). The MIND Foundation is an official study partner providing expertise, personnel, and additional funding.
The acronym “EPIsoDE” (Efficacy and safety of Psilocybin In treatment-reSistant majOr DEpression) summarizes the aim of the study: To investigate whether psilocybin administered under supportive conditions in a controlled, randomized, double-blind design is a safe and effective treatment for depression patients whose symptoms cannot be adequately reduced with antidepressants. Over the course of the study, 144 patients will be treated in Mannheim and Berlin. The rationale and study design are explained in detail in a recent article published in the scientific journal Neuroscience Applied.
uniMIND is a global network of academic journal clubs, open to academics of all levels and disciplines with the focus on mind, brain, and psychedelic research. Local groups operate mostly autonomously through regular meetings in which research literature, academic talks, documentaries, or projects are discussed. Besides, there are monthly central web-sessions with invited authors and the yearly uniMIND Symposium.
Organisation
Address: Boxhagener Straße 82a 10245 Berlin
Country: Germany
Email: info@mind-foundation.org
